Articles of interest – International Liver Cancer Association

Cabozantinib in patients with advanced and progressing hepatocellular carcinoma

The New England Journal of Medicine, 5 July 2018

Selective internal radiation therapy versus sorafenib in locally advanced hepatocellular carcinoma

Journal of Clinical Oncology, 1 July 2018

Mutational landscape of a chemically-induced mouse model of liver cancer

Journal of Hepatology, 26 June 2018

The protein histidine phosphatase LHPP is a tumour suppressor

Nature, 29 March 2018

Splenic erythroblast-like Ter-cells promote liver cancer progression

Cell., 19 April 2018

Immune landscape in liver cancer and its additional impact on histological and molecular classification

Hepatology, 30 March 2018

Lenvatinib, a new first-line treatment in advanced HCC

The Lancet, 24 March 2018

RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2

Hepatology, 24 November 2017

Percutaneous radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma

Journal of Clinical Oncology, 20 February 2018

Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

Gut., 13 February 2018

12 3 4 5 6 7 8

page 1 of 8

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search